| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |